首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1730127

咳嗽·感冒·过敏:大流行病后的全球CCA的机会的阐明

Cough, Cold & Allergy: Unravelling CCA Opportunities in a Post-Pandemic World

出版日期: 2025年07月31日 | 出版商:

Nicholas Hall Group of Companies | 英文 | 订单完成后即时交付

价格

简介目录

咳嗽、感冒和过敏是2024年全球CHC（慢性中枢神经系统疾病）类别中成长最慢的。虽然许多产品的需求是由季节性疾病的流行和严重程度所驱动的，但行销人员正在寻找能够推动全年销售的新利基市场，例如高空气污染水平。在持续的成分限制下， "天然" 趋势正在推动新产品开发活动，但消费者也在寻求能够解决多种症状并快速缓解的 "一体化" 产品。随着产品转换活动继续成为成长和创新的关键驱动力，过敏药物预计将蓬勃发展。随着免疫相关产品（包括咳嗽和感冒品牌及补充剂）的需求降温，行销人员可能需要寻找新的利基市场。

本报告探讨并分析了全球咳嗽、感冒和过敏市场，提供按国家和类别划分的销售数据、各个品牌的表现以及截至 2029 年和 2034 年的预测。

深入探讨 10 个独立市场

巴西
印度
波兰
中国

法国
德国
义大利
日本

英国
美国

选择作为简略的附加的市场

澳洲

加拿大

墨西哥

俄罗斯

An in-depth exploration of the CHC Cough, Cold & Allergy market globally, including Cough remedies, Systemic cold & flu, Allergy remedies, Decongestants, Sore throat remedies and more
Immunity-related VMS - including vitamin C, zinc and immune supplements - also investigated
Very latest year-end 2024 sales from the just-published DB6, our dedicated CHC sales database, plus historical growth rates back to 2020
Internet & mail order channel sales for every market profiled
Coverage of marketer activity, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
Coverage of 14 major markets from around the world, with topline sales, brand performances, latest developments, launches and promotional campaigns
A look to the future includes long-term forecast sales for all categories and countries to 2029 & 2034, plus the most up-to-date short-term forecasts (to 2025 & 2026)

Cough, Cold & Allergy was the slowest-growing CHC category globally in 2024, as systemic cold & flu and cough remedies progressed at a modest rate, but the outlook is steady, with growth trends returning to a more normal level. While demand for many products is dependent on incidence and severity of seasonal pathologies, marketers are identifying new niches to drive year-round sales such as high levels of air pollution. As restrictions continue on various ingredients, the trend towards "naturals" has fuelled NPD activity, but consumers are also demanding multi-symptom, fast-acting or "all-in-one" products. Allergy remedies look set for better growth, as switch activity remains a robust influencer of growth and innovation in the future. As demand for immunity-related products cools (among cough & cold brands and supplements), marketers may need to find new niches.

This report will investigate pressing issues affecting the global CCA market, digging into multiple areas of interest and highlighting inherent opportunities. Examining ten core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our CCA report will investigate the untapped potential in this CHC category.

The report features the latest end-2024 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2029 and 2034. Coverage extends to the online channel, with internet & mail order sales of CCA included in the topline and a dedicated section in each country profile.

Diving into the factors affecting individual Cough, Cold & Allergy markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 10 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets.

"1" selected markets only.

"2" sales tracked under VMS in DB6 (vitamin C, zinc, immune supplements).

Assessing the short-term outlook, the report includes full year 2025 & 2026 forecasts for all categories in each market profiled.

With launch activity in CCA picking up again after several years of decline, has the impetus shifted from quantity to quality? New product development is explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more.

Key questions investigated in this report:

How do key growth drivers, consumer choices and competitive landscape differ from market to market?
Which marketers and brands have proved most successful?
Has NPD benefited the CCA market and can it be a future growth driver?
What are the opportunities for e-commerce and digital marketing for CCA brands?
Can new niches and underserved demographics be identified?
How is the adjacent category of immunity-related supplements faring?
What is the outlook for CCA and where can opportunities be found?

10 individual markets profiled in depth:

Brazil
India
Poland
China

France
Germany
Italy
Japan

Plus additional markets in brief:

Australia

Canada

Mexico

Russia

Executive Summary

Global CCA snapshot
Category review
Outlook, forecasts & opportunities

USA

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Asthma remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

China

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Asthma remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

Germany

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

Japan

Overview
Cough remedies
Systemic cold & flu
Topical decongestants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Outlook, forecasts & opportunities

Italy

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Sore throat remedies & medicated confectionery
Allergy remedies
Immunity-related VMS
Outlook, forecasts & opportunities

India

Overview
Cough remedies
Systemic cold & flu
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

Poland

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

Brazil

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

France

Overview
Cough remedies
Systemic cold & flu
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Internet & mail order channel
Immunity-related VMS
Outlook, forecasts & opportunities

UK

Overview
Cough remedies
Systemic cold & flu
Systemic decongestants
Topical decongestants
Chest rubs & inhalants
Sore throat remedies & medicated confectionery
Allergy remedies
Immunity-related VMS
Outlook, forecasts & opportunities

Additional Markets

Australia
Canada
Mexico
Russia

Outlook

Short-term forecasts & opportunities
Long-term forecasts & opportunities

02-2729-4219

+886-2-2729-4219

License/价格